Sentiment Trading

Beyond Air, Inc. is a medical device and biopharmaceutical company focused on developing nitric oxide formulations and delivery systems to transform the treatment landscape for respiratory conditions.

Acumen Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company pioneering a novel disease-modifying approach to tackle the root causes of Alzheimer’s disease.

Caris Life Sciences reports strong financial performance, including an 81% revenue increase, and strategic moves to expand its global footprint and diversify its portfolio.

Absci Corporation, a synthetic biology company, reported Q2 2025 financials with a slight improvement in quarterly loss per share and a 4.72% reduction in revenue, but analysts remain optimistic about its potential for growth and innovation.

GB Sciences, Inc. is a pioneering company dedicated to developing innovative cannabis-based therapeutics and treatments for a wide range of health conditions.

Armata Pharmaceuticals is a clinical-stage biotech company focused on developing innovative bacteriophage therapies to combat multidrug-resistant bacterial infections and preventable infectious diseases.

Moleculin Biotech, Inc. is a pioneering pharmaceutical company developing innovative anti-cancer therapies and treatments, offering hope to patients and a beacon of resilience in the biotechnology sector.

Annovis Bio Inc, a biotech company focused on developing treatments for Alzheimer’s and Parkinson’s disease, faces significant financial challenges but holds promise for revolutionizing patient care with its innovative research.

GRAIL, Inc. is a biotechnology company focused on early cancer detection, with a mission to improve patient outcomes through timely diagnosis and revolutionize cancer screening processes.

Lyra Therapeutics, a clinical-stage biotech company, is focused on developing innovative treatments for chronic rhinosinusitis, with its stock currently valued at $10.7 million.